Non–AIDS-Defining Cancers

  • Authors: David Aboulafia, MD (More Info)
  • Editors in Chief: Joseph J. Eron, Jr., MD; Daniel R. Kuritzkes, MD
  • Last Reviewed: 11/15/21 (What's New)

Summary

  • Challenges to management of NADCs:
    • Reactive lymphadenopathy or other HIV-related imaging abnormalities can interfere with tumor staging[Bhargava 2008; Warwick 2011]
    • HIV-related comorbidities may result in poor performance status, which can affect response to treatment

Action required

Keywords: Cancer, Drug-Drug Interactions

©2020 Clinical Care Options, LLC. All Rights Reserved.

The materials published via inPractice® reflect the views of the reviewers or authors of the material, not those of Clinical Care Options, LLC, the accredited provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.